跳至主要内容
临床试验/CTRI/2017/09/009618
CTRI/2017/09/009618已完成2 期

An open label, interventional, multi-center, prospective clinical study to Evaluation of Efficacy and Safety of JP-16 Capsules in Patients Suffering from Mild to Moderate Sexual Dysfunction - NI

Chatarubhuj Pharmaceutical Co0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects who have scored 22 to 25 on the Erectile Function (EF) domain of the International Index of Erectile Function (IIEF) at screening.
  • 2. Subject without any organic cause of Sexual Dysfunction.
  • 3. Subjects should be in an active stable sexual relationship for the duration of study

排除标准

  • 1. Subjects with major illnesses and sexual dysfunction due to anatomical, surgical or pharmacological causes
  • 2. Subjects with total erectile failure or any other sexual disorder
  • 3. Subjects with history of disorders that may cause priapism
  • 4. Subjects with history of major psychiatric disorder
  • 5. Subjects with history of central nervous system disorders such as stroke, transient ischemic attacks or spinal cord injury or pelvic surgery
  • 6. Patients with preexisting systemic disease necessitating long-term medications, genetic and endocrinal disorders

研究者

发起方
Chatarubhuj Pharmaceutical Co

相似试验